EPH247 Survival and Risk of Death Analysis of Patients with Myelofibrosis Treated with Ruxolitinib

The aim of this study is to analyze the risk of death and survival of patients with MF treated with ruxolitinib in comparison with the group on standard therapy before ruxolitinib inclusion in the national reimbursement system of Bulgaria.
Source: Value in Health - Category: International Medicine & Public Health Authors: Source Type: research